Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells.

Mastelic-Gavillet B, Navarro Rodrigo B, Décombaz L, Wang H, Ercolano G, Ahmed R, Lozano LE, Ianaro A, Derré L, Valerio M, Tawadros T, Jichlinski P, Nguyen-Ngoc T, Speiser DE, Verdeil G, Gestermann N, Dormond O, Kandalaft L, Coukos G, Jandus C, Ménétrier-Caux C, Caux C, Ho PC, Romero P, Harari A, Vigano S.

J Immunother Cancer. 2019 Oct 10;7(1):257. doi: 10.1186/s40425-019-0719-5.

PMID:
31601268
2.

Netting Neutrophils Activate Autoreactive B Cells in Lupus.

Gestermann N, Di Domizio J, Lande R, Demaria O, Frasca L, Feldmeyer L, Di Lucca J, Gilliet M.

J Immunol. 2018 May 15;200(10):3364-3371. doi: 10.4049/jimmunol.1700778. Epub 2018 Apr 9.

3.

STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.

Demaria O, De Gassart A, Coso S, Gestermann N, Di Domizio J, Flatz L, Gaide O, Michielin O, Hwu P, Petrova TV, Martinon F, Modlin RL, Speiser DE, Gilliet M.

Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15408-13. doi: 10.1073/pnas.1512832112. Epub 2015 Nov 25.

4.

Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.

Simonetta F, Gestermann N, Bloquet S, Bourgeois C.

PLoS One. 2014 Dec 8;9(12):e113314. doi: 10.1371/journal.pone.0113314. eCollection 2014.

5.

Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome.

Belkhir R, Gestermann N, Koutero M, Seror R, Tost J, Mariette X, Miceli-Richard C.

Scand J Immunol. 2014 Jan;79(1):37-42. doi: 10.1111/sji.12121.

6.

Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.

Gestermann N, Koutero M, Belkhir R, Tost J, Mariette X, Miceli-Richard C.

Eur Cytokine Netw. 2012 Oct-Dec;23(4):166-72. doi: 10.1684/ecn.2012.0316.

7.

Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis.

Simonetta F, Gestermann N, Martinet KZ, Boniotto M, Tissières P, Seddon B, Bourgeois C.

PLoS One. 2012;7(5):e36596. doi: 10.1371/journal.pone.0036596. Epub 2012 May 7.

8.

Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis.

Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C.

Eur Cytokine Netw. 2011 Jun;22(2):88-102. doi: 10.1684/ecn.2011.0285. Review.

9.

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling.

Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Mariette X, Miceli-Richard C.

Genes Immun. 2010 Jul;11(5):432-8. doi: 10.1038/gene.2010.29. Epub 2010 Jun 10. Erratum in: Genes Immun. 2010 Jul;11(5):446.

PMID:
20535138
10.

The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.

Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Lebon P, Becquemont L, Mariette X.

Arthritis Rheum. 2009 Jul;60(7):1991-7. doi: 10.1002/art.24662.

11.

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies.

Miceli-Richard C, Gestermann N, Amiel C, Sellam J, Ittah M, Pavy S, Urrutia A, Girauld I, Carcelain G, Venet A, Mariette X.

Arthritis Res Ther. 2009;11(3):R77. doi: 10.1186/ar2708. Epub 2009 May 26.

12.

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.

Ann Rheum Dis. 2007 Jun;66(6):790-7. Epub 2006 Dec 21.

Supplemental Content

Loading ...
Support Center